Document resource
Hypoglycaemia, or low blood sugar (BS), is a potentially serious side effect of diabetes treatment that adversely impacts brain function. 1 Newer classes of diabetes medications such as glucagon-like peptide-1 (GLP-1) agonists, sodium-glucose co-transporter-2 (SGLT-2) inhibitors, dipeptidyl peptidase-4 inhibitors and thiazolidinediones (TZDs) have minimal risk of hypoglycaemia when used on their own.2 Moreover, newer BS management approaches using continuous glucose monitors (CGMs) provide a tool to recognise impending low BS levels as a means to prevent clinical hypoglycaemia.3 Little is known about how these developments affect hypoglycaemic emergencies. We describe temporal trends in emergency medical services (EMS) incidents involving hypoglycaemia.